ritalin la 40 mg capsules
novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 40 mg, sacchari sphaerae corresp. saccharum mg et saccharum max. 225.89 mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), e 172 (nigrum), e 172 (rubrum), drucktinte: pro capsula, lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika
ritalin la 10 mg capsules
novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum max. 56.48 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika
ritalin la 60 mg capsules
novartis pharma schweiz ag - methylphenidati hydrochloridum - capsules - methylphenidati hydrochloridum 60 mg, sacchari sphaerae, macrogolum 6000, saccharum max. 338.85 mg et ammonio methacrylatis copolymerum b, maydis amylum, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, aqua, color.: e 171, e 172, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika
naelia vaginalring
mepha pharma ag - etonogestrelum, ethinylestradiolum - vaginalring - etonogestrelum 11,7 mg, ethinylestradiolum 2,7 mg, excipiens pour la préparation. - hormonale de contraception - synthetika
methylphenidat-mepha la 10mg depocaps
mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 10 mg, excipiens pro de la capsule. - psychotonikum - synthetika
methylphenidat-mepha la 20mg depocaps
mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 20 mg, excipiens pro de la capsule. - psychotonikum - synthetika
methylphenidat-mepha la 30mg depocaps
mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 30 mg, excipiens pro de la capsule. - psychotonikum - synthetika
methylphenidat-mepha la 40mg depocaps
mepha pharma ag - methylphenidati hydrochloridum - depocaps - methylphenidati hydrochloridum 40 mg, excipiens pro de la capsule. - psychotonikum - synthetika
gencebok
gennisium pharma - du citrate de caféine - l'apnée - psychoanaleptics, - le traitement primaire de l'apnée du sommeil des nouveau-nés prématurés.
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - des antiépileptiques,des - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.